Modelling of cerebral tuberculosis: Hope for continuous research in solving the enigma of the bottom Billion's disease

Malaysian Journal of Medical Sciences

Volumn 18, Issue 1, 2011, Pages 12-15

  Pando, Rogelio Hernández ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Experimental models; Infectious diseases; Meningeal tuberculosis; Mice; Mycobacterium; Virulence

Indexed keywords

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BRAIN INFECTION; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CEREBROSPINAL FLUID; DISEASE MODEL; DISEASE SEVERITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNE RESPONSE; MEDICAL RESEARCH; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; RESPIRATORY TRACT INFECTION; TUBERCULOUS MENINGITIS;

EID: 79551560218     PISSN: 1394195X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Garg RK. Tuberculosis of the central nervous system. Postgrad Med J. 1999;75(881):133-140.
2. Katti MK. Pathogenesis, diagnosis, treatment, and outcome aspects of cerebral tuberculosis. Med Sci Monit. 2004;10(9):RA215-229.
3. Rich AR, McCordock HA. The pathogenesis of tubercular meningitis. Bull John Hopkins Hosp. 1933;52:5-13.
4. Tsenova L, Sokol K, Freedman VH, Kaplan G. A combination of thalidomide plus antibiotics protect rabbits from mycobacterial meningitis-associated death. J Infect Dis. 1998;177(6):1563-1572.
5. Tsenova L, Bergtold A, Freedman VH, Young RA, Kaplan G. Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc Natl Acad Sci USA. 1999;96(10): 5657-5662.
6. van Well GT, Wieland CW, Florquin S, Roord JJ, van der Poll T, van Furth AM. A new murine model to study the pathogenesis of tuberculous meningitis. J Infect Dis. 2007;195(5):694-697.
7. Wu HS, Kolonoski P, Chang YY, Bermudez LE. Invasion of the brain and chronic central nervous system infection after systemic Mycobacterium avium complex infection in mice. Infect Immun. 2000;68(5):2979-2984.
8. Bolin CA, Whipple DL, Khanna KV, Risdhal JM, Peterson PK, Molitor TW. Infection of swine with Mycobacterium bovis as a model of human tuberculosis. J Infect Dis. 1997;176(6):1559-1566.
9. Huang SH, Jong AY. Cellular mechanisms of microbial proteins contributing to invasion of the blood-brain barrier. Cell Microbiol. 2001;3(5):277-287.
10. Jain SK, Paul-Satyassela M, Lamichhane G, Kim KS, Bishai WR. Mycobacterium tuberculosis invasion and traversal across an in vitro human blood-brain barrier as a pathogenic mechanism for central nervous system tuberculosis. J Infect Dis. 2006;193(9):1287-1295.
11. Arvanitakis Z, Long RL, Herschfield ES, Manfreda J, Kabani A, Kunimoto D, et al. M. tuberculosis molecular variation in CNS infection: Evidence for strain-dependent neurovirulence. Neurology. 1998;50(6):1827-1832.
12. Hernandez Pando R, Aguilar D, Cohen I, Guerrero M, Ribon W, Acosta P, et al. Specific bacterial genotype of Mycobacterium tuberculosis cause extensive dissemination and brain infection in an experimental model. Tuberculosis (Edinb). 2010;90(4):268-277.
13. Hawn TR, Dustan SJ, Thwaites GE, Simmons CP, Thuong NT, Lan NT, et al. A polymorphism in Tollinterleukin 1 receptor domain containing adaptor protein is associated with suceptibility to meningealtuberculosis. J Infect Dis. 2006;194(8):1127-1134.